Wallstreet Hotties of the Day: Citigroup Inc. (NYSE:C), BioPharmX Corporation (NYSE:BPMX)

Citigroup Inc. (NYSE:C)

The shares of Citigroup Inc. (NYSE:C) started off the last trading session with the price of $73.47 while closing the day with the price of $72.7. The shares of Citigroup Inc. (NYSE:C) Fell -1.05% with the Loss of -0.77 points.

The shares of Citigroup Inc. (NYSE:C) traded with the day volume of 14.92 Million shares whereas its average trading volume is 16.49 Million.

While analyzing the past performance of the stock we can see that the shares of Citigroup Inc. (NYSE:C) Loss -4.37% in the last week while Falling -5.68% in the last month. Past quarter performance shows the red light with -1.65%. The semi-annual and annual performance shows 5.3% and 20.42% respectively.

Some critical values of the shares of Citigroup Inc. (NYSE:C) to be discussed here are: the beta which shows the value at 1.5 while Average True Range of Citigroup Inc. (NYSE:C) demonstrate the value at 1.57. The weekly and monthly volatility of the shares of Citigroup Inc. (NYSE:C) are indicated at 1.95% and 1.97%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 38.32.

While studying the financial position of the shares of Citigroup Inc. (NYSE:C), we can see that the Market capitalization of the company is at 191.88 Billion. The shares outstanding for the company is 2.64 Billion and the shares float stands at 2.64 Billion. The income of the company stand at 14.66 Billion while the sales stand at 61.2 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 5.44, Price to Earnings or P/E is at 13.37, Price to Sales P/S show the value of 3.14, the Return on Asset ROA stood at -0.004 and the Return on Equity ROE depicted at -0.04 while Return on Investment ROI is at 0.076.


BioPharmX Corporation (NYSE:BPMX)

BioPharmX Corporation (NYSE:BPMX) started its previous trading session at $0.26 and closed at $0.26 showing a Fell of -1.63 Percent.

The Company traded with an average Volume of 14.07 Million whereas, its Day Volume stood at 14.4 Million.

Looking at the performance of the stock, BioPharmX Corporation (NYSE:BPMX) Loss -21.36% in the last week in its shares price and 82.76% in the last month. Quarterly performance shows a green of 137.03 Percent while Semi-Annual and Annual performances shows a -13.11 and -49.52 percent respectively.

Beta for BioPharmX Corporation (NYSE:BPMX) stands at -0.69 while the ATR (average true range) is at 0.04. The Stock’s Weekly and Monthly Volatility is 14.31% and 14.98% respectively showing a RSI value of 54.11.

While studying the financial position of the shares of BioPharmX Corporation (NYSE:BPMX), we can see that the Market capitalization of the company is at 36.45 Million. The shares outstanding for the company is 137.55 Million and the shares float stands at 119.39 Million.

The Company generated an income of -18000000 and the sales of 70000 in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.27 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 528.27 respectively.

The Return on Assets stands at -3.269, ROE shows a value of 0 and ROI for BioPharmX Corporation (NYSE:BPMX) is 0 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment